Annual Cash & Cash Equivalents
$5.90 M
-$6.21 M-51.27%
December 31, 2023
Summary
- As of February 7, 2025, SLRX annual cash & cash equivalents is $5.90 million, with the most recent change of -$6.21 million (-51.27%) on December 31, 2023.
- During the last 3 years, SLRX annual cash & cash equivalents has fallen by -$5.22 million (-46.94%).
- SLRX annual cash & cash equivalents is now -91.15% below its all-time high of $66.69 million, reached on December 31, 2015.
Performance
SLRX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$3.28 M
+$11.20 K+0.34%
September 30, 2024
Summary
- As of February 7, 2025, SLRX quarterly cash and cash equivalents is $3.28 million, with the most recent change of +$11.20 thousand (+0.34%) on September 30, 2024.
- Over the past year, SLRX quarterly cash and cash equivalents has dropped by -$1.09 million (-24.91%).
- SLRX quarterly cash and cash equivalents is now -97.03% below its all-time high of $110.52 million, reached on March 31, 2015.
Performance
SLRX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
SLRX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -51.3% | -24.9% |
| 3 y3 years | -46.9% | -71.5% |
| 5 y5 years | -40.0% | -71.5% |
SLRX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -79.8% | at low | -88.8% | +0.3% |
| 5 y | 5-year | -79.8% | +57.8% | -91.0% | +0.3% |
| alltime | all time | -91.2% | +57.8% | -97.0% | +0.3% |
Salarius Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.28 M(+0.3%) |
| Jun 2024 | - | $3.27 M(-25.2%) |
| Mar 2024 | - | $4.37 M(-25.9%) |
| Dec 2023 | $5.90 M(-51.3%) | $5.90 M(-22.2%) |
| Sep 2023 | - | $7.58 M(-34.3%) |
| Jun 2023 | - | $11.54 M(+24.5%) |
| Mar 2023 | - | $9.27 M(-23.4%) |
| Dec 2022 | $12.11 M(-58.6%) | $12.11 M(-28.0%) |
| Sep 2022 | - | $16.82 M(-25.7%) |
| Jun 2022 | - | $22.65 M(-6.4%) |
| Mar 2022 | - | $24.19 M(-17.2%) |
| Dec 2021 | $29.21 M(+162.8%) | $29.21 M(-8.4%) |
| Sep 2021 | - | $31.90 M(-3.6%) |
| Jun 2021 | - | $33.08 M(-9.6%) |
| Mar 2021 | - | $36.61 M(+229.3%) |
| Dec 2020 | $11.12 M(+197.4%) | $11.12 M(+16.3%) |
| Sep 2020 | - | $9.56 M(+32.3%) |
| Jun 2020 | - | $7.22 M(-25.1%) |
| Mar 2020 | - | $9.65 M(+158.0%) |
| Dec 2019 | $3.74 M | $3.74 M(-6.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $4.00 M(-38.6%) |
| Jun 2019 | - | $6.51 M(-10.7%) |
| Mar 2019 | - | $7.30 M(-25.8%) |
| Dec 2018 | $9.83 M(-48.8%) | $9.83 M(-24.2%) |
| Sep 2018 | - | $12.96 M(-17.7%) |
| Jun 2018 | - | $15.76 M(-28.2%) |
| Mar 2018 | - | $21.95 M(+14.4%) |
| Dec 2017 | $19.19 M(-14.4%) | $19.19 M(-4.8%) |
| Sep 2017 | - | $20.15 M(-48.5%) |
| Jun 2017 | - | $39.13 M(+85.7%) |
| Mar 2017 | - | $21.07 M(-6.0%) |
| Dec 2016 | $22.42 M(-66.4%) | $22.42 M(-19.5%) |
| Sep 2016 | - | $27.83 M(-28.5%) |
| Jun 2016 | - | $38.94 M(-27.9%) |
| Mar 2016 | - | $54.00 M(-19.0%) |
| Dec 2015 | $66.69 M(+97.0%) | $66.69 M(-25.2%) |
| Sep 2015 | - | $89.16 M(-15.9%) |
| Jun 2015 | - | $106.01 M(-4.1%) |
| Mar 2015 | - | $110.52 M(+204.5%) |
| Dec 2014 | $33.85 M | - |
| Sep 2014 | - | $36.29 M |
FAQ
- What is Salarius Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Salarius Pharmaceuticals?
- What is Salarius Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Salarius Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Salarius Pharmaceuticals?
- What is Salarius Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Salarius Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of SLRX is $5.90 M
What is the all time high annual cash & cash equivalents for Salarius Pharmaceuticals?
Salarius Pharmaceuticals all-time high annual cash & cash equivalents is $66.69 M
What is Salarius Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, SLRX annual cash & cash equivalents has changed by -$6.21 M (-51.27%)
What is Salarius Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of SLRX is $3.28 M
What is the all time high quarterly cash and cash equivalents for Salarius Pharmaceuticals?
Salarius Pharmaceuticals all-time high quarterly cash and cash equivalents is $110.52 M
What is Salarius Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, SLRX quarterly cash and cash equivalents has changed by -$1.09 M (-24.91%)